We are a national coalition of AIDS activists, many living with HIV/AIDS,working together to end the AIDS epidemic by advancing research on HIV/AIDS

News


kaisernetwork.org: HIV/AIDS Daily Report


kaisernetwork.org: Kaiser Health Disparities Report


HIV-AIDS News

Member Log-in

User:
Password:
Forget Password?
 

Search

 

Bristol-Myers Squibb


Community Affairs Manager:

Jessica Riviere

 

Approved Drugs:

1) Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets

2) Baraclude® (entecavir) Nucleoside analogue. Tablets and Oral Solution for Hep B

3) Reyataz® (atazanavir sulfate) Protease inhibitor (PI). Capsules

4) Sustiva® (efavirenz) Non-nucleoside reverse transcriptase inhibitor (NNRTI). Capsules and Tablets


Patient Assistance Program:


Telephone: 888-281-8981 (Baraclude, Reyataz, and Sustiva); 866-290-4767 (Atripla)


Website: http://www.bms.com/static/patient_assistance/data/programs.html

Corporate website:  www.bms.com